Home Newsletters Pancreatic Cell News CHK1 Protects Oncogenic KRAS-Expressing Cells from DNA Damage and Is a Target...

CHK1 Protects Oncogenic KRAS-Expressing Cells from DNA Damage and Is a Target for Pancreatic Cancer Treatment

0
Pharmacologic inhibition of CHK1 alone caused apoptotic growth suppression of both PDAC cell lines and organoids, which correlated with loss of MYC expression.
[Cell Reports]
6445212 AAAAAAAA items 1 apa 0 default asc 1 169531 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full ArticleGraphical Abstract
Exit mobile version